Statistics from Altmetric.com
Coeliac disease is a gluten-mediated autoimmune disorder that occurs in genetically predisposed individuals carrying the HLA-DQ2 and/or HLA-DQ8 alleles. Most patients with coeliac disease can be effectively managed by a strict gluten-free diet. Approximately, 5% of adult patients with coeliac disease lose their clinical and histological response to a strict gluten-free diet and develop refractory coeliac disease (RCD). Based on the clonal and immunophenotypical features of intraepithelial lymphocytes (IELs), RCD is divided into two subtypes. In RCD-I, IELs are polyclonal and show a normal phenotype, while in RCD-II, IELs are monoclonal and immunophenotypically aberrant, expressing cytoplasmic CD3ε but not surface CD3ε, CD8 and T cell receptor (TCR) antigens.1–3
Coeliac disease mainly causes enteropathy of the small intestine, but can involve the entire gastrointestinal tract. Apart from the classic intestinal syndrome, patients with coeliac disease also show a wide spectrum of extraintestinal manifestations and 10–20% of patients with coeliac disease present with dermatitis herpetiformis. Here, we report a case of RCD with subsequent presentation of skin lesions and show that the neoplastic intraepithelial T cells of the gut also preferentially invade the epidermis.
The patient, a 47-year-old man, presented with a 2-year history of epigastric pain, occasional nausea and vomiting, intermittent light and bulky stool, and weight loss. Oesophagogastroduodenoscopy showed erosion and inflammation in the body and antrum of the stomach and proximal duodenum, and mild erythema in the distal duodenum. Campylobacter-like organism (CLO) test …
Contributors HL collected the experimental data. RKF, SMG and JW provided clinical input. AR, PW, PGI and M-QD reviewed the histology and immunohistochemistry. M-QD analysed the data and drafted the manuscript. All authors reviewed and commented on the manuscript and approved its submission.
Funding The research in M-QD lab was supported by grants from Leukaemia & Lymphoma Research, UK, the Kay Kendal Leukaemia Fund, UK.
Competing interests None.
Patient consent Obtained.
Ethics approval Oxfordshire REC A.
Provenance and peer review Not commissioned; externally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.